» Articles » PMID: 20096914

Functional Properties of the HIV-1 Subtype C Envelope Glycoprotein Associated with Mother-to-child Transmission

Overview
Journal Virology
Specialty Microbiology
Date 2010 Jan 26
PMID 20096914
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Understanding the properties of viruses capable of establishing infection during perinatal transmission of HIV-1 is critical for designing effective means of limiting transmission. We previously demonstrated that the newly transmitted viruses (in infant) were more fit in growth, as imparted by their envelope glycoproteins, than those in their corresponding mothers. Here, we further characterized the viral envelope glycoproteins from six mother-infant transmission pairs and determined whether any specific envelope functions correlate with HIV-1 subtype C perinatal transmission. We found that most newly transmitted viruses were less susceptible to neutralization by their maternal plasma compared to contemporaneous maternal viruses. However, the newly transmitted variants were sensitive to neutralization by pooled heterologous plasma but in general were resistant to IgG1 b12. Neither Env processing nor incorporation efficiency was predictive of viral transmissibility. These findings provide further insight into the characteristics of perinatally transmissible HIV-1 and may have implications for intervention approaches.

Citing Articles

HIV-1 Entry and Prospects for Protecting against Infection.

Bruxelle J, Trattnig N, Mureithi M, Landais E, Pantophlet R Microorganisms. 2021; 9(2).

PMID: 33499233 PMC: 7911371. DOI: 10.3390/microorganisms9020228.


Neutralization Sensitivity of a Novel HIV-1 CRF01_AE Panel of Infectious Molecular Clones.

Chenine A, Merbah M, Wieczorek L, Molnar S, Mann B, Lee J J Acquir Immune Defic Syndr. 2018; 78(3):348-355.

PMID: 29528942 PMC: 5997515. DOI: 10.1097/QAI.0000000000001675.


Unique Phenotypic Characteristics of Recently Transmitted HIV-1 Subtype C Envelope Glycoprotein gp120: Use of CXCR6 Coreceptor by Transmitted Founder Viruses.

Ashokkumar M, Aralaguppe S, Tripathy S, Hanna L, Neogi U J Virol. 2018; 92(9).

PMID: 29491151 PMC: 5899188. DOI: 10.1128/JVI.00063-18.


Recent Insights into the HIV/AIDS Pandemic.

Becerra J, Bildstein L, Gach J Microb Cell. 2017; 3(9):451-475.

PMID: 28357381 PMC: 5354571. DOI: 10.15698/mic2016.09.529.


Breast milk and in utero transmission of HIV-1 select for envelope variants with unique molecular signatures.

Nakamura K, Heath L, Sobrera E, Wilkinson T, Semrau K, Kankasa C Retrovirology. 2017; 14(1):6.

PMID: 28122636 PMC: 5267468. DOI: 10.1186/s12977-017-0331-z.


References
1.
Derdeyn C, Decker J, Bibollet-Ruche F, Mokili J, Muldoon M, Denham S . Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science. 2004; 303(5666):2019-22. DOI: 10.1126/science.1093137. View

2.
Zhang H, Hoffmann F, He J, He X, Kankasa C, Ruprecht R . Evolution of subtype C HIV-1 Env in a slowly progressing Zambian infant. Retrovirology. 2005; 2:67. PMC: 1308862. DOI: 10.1186/1742-4690-2-67. View

3.
Rong R, Gnanakaran S, Decker J, Bibollet-Ruche F, Taylor J, Sfakianos J . Unique mutational patterns in the envelope alpha 2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1. J Virol. 2007; 81(11):5658-68. PMC: 1900276. DOI: 10.1128/JVI.00257-07. View

4.
Binley J, Wrin T, Korber B, Zwick M, Wang M, Chappey C . Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J Virol. 2004; 78(23):13232-52. PMC: 524984. DOI: 10.1128/JVI.78.23.13232-13252.2004. View

5.
Bures R, Morris L, Williamson C, Ramjee G, Deers M, Fiscus S . Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa. J Virol. 2002; 76(5):2233-44. PMC: 135941. DOI: 10.1128/jvi.76.5.2233-2244.2002. View